(R)-1-((Benzyloxy)carbonyl)piperidine-2-carboxylic acid, 95.0%, 10g

[1,2,4]TRIAZOLO[1,5-A]PYRIDINE-5-CARBOXYLIC ACID, 95.0%, 1g

2-((tert-Butoxycarbonyl)amino)-3-(4-chlorophenyl)propanoic acid, 95.0%, 25g

Transition piece, 45/40, 60/46, 1 Piece

Methyl 3-(4-Hydroxyphenyl)propionate>98.0%(GC)25g

2-(3-Bromo-4-fluorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 1g

2-(Bromomethyl)-1,3-benzothiazole>98.0%(GC)1g

1-(2-Methoxyethyl)piperidin-4-one, 98%, 1g

4-(Piperidin-3-ylthio)pyridine dihydrochloride, 97%, 500mg

2,6-Bis(trifluoromethyl)-4-hydroxyquinoline, 95.0%, 5g

5,7-Dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-6-methoxy-4H-chromen-4-one, 95.0%, 50mg

2-((Dimethylamino)methyl)acrylic acid, 98% (stabilized with MEHQ), 250mg

2,3-Butanediol (mixture of stereoisomers), 97.0%, 5g